首页|miR-891a-5p及miR-383-5p与激素受体阳性早期乳腺癌术后发生远处转移的关系探讨

miR-891a-5p及miR-383-5p与激素受体阳性早期乳腺癌术后发生远处转移的关系探讨

扫码查看
目的 探讨微小RNAs(miRNAs,miR)-891a-5p及miR-383-5p与激素受体(HR)阳性早期乳腺癌术后发生远处转移的关系.方法 62 例HR阳性早期(T1~2N0M0 期)乳腺癌患者,根据术后是否出现远处转移分为远处转移组(28 例,出现远处转移)和未远处转移组(34 例,未出现远处转移).收集两组的临床乳腺癌标本,并检测组织的miRNAs表达水平.比较两组miR-891a-5p、miR-383-5p、miR-1295a表达水平,分析miR-891a-5p、miR-383-5p、miR-1295a对乳腺癌远处转移的诊断效能;比较两组miR-661、miR-296-3p、miR-128-3p表达水平,分析miR-891a-5p、miR-383-5p、miR-1295a表达水平与无远处转移生存率(DMFS)之间的关系.结果 远处转移组miR-891a-5p、miR-383-5p、miR-1295a表达水平明显较未远处转移组减少,差异倍数分别为-2.519、-1.812 和-1.443;远处转移组miR-891a-5p表达(1.099±0.899)明显低于未远处转移组的(2.768±2.194)(P<0.05).miR-891a-5p低表达(<1.12)预测远处转移的敏感度和特异度分别为 71.4%和 82.4%,曲线下面积(AUC)为0.825(P=0.0000<0.01);miR-383-5p低表达(<1.15)预测远处转移的敏感度和特异度分别为 53.4%和85.3%,AUC为 0.738(P=0.0013<0.01);而miR-1295a低表达(<2.08)预测远处转移的敏感度和特异度分别为 82.1%和 50.0%,AUC仅为 0.677(P=0.0175<0.05).在诊断效能上,miR-891a-5p诊断乳腺癌远处转移的AUC、敏感度、阳性预测值、阴性预测值均优于miR-383-5p,miR-1295a诊断效能最差,表明miR-891a-5p、miR-383-5p低表达能预测HR阳性早期乳腺癌的远处转移.远处转移组的miR-661、miR-296-3p、miR-128-3p表达水平均低于未远处转移组,差异具有统计学意义(P<0.05).62 例患者的随访时间为 59~131 个月,中位随访时间为 81 个月.miR-891a-5p低表达患者的中位DMFS时间为48个月,5年DMFS仅为38.5%,低于miR-891a-5p高表达的86.1%(P<0.01).miR-383-5p低表达患者的中位DMFS时间为 52 个月,5 年DMFS为 35.0%,低于miR-383-5p高表达的 73.8%(P<0.01);miR-1295a低表达患者的中位DMFS时间为65个月,miR-1295a高、低表达患者的5年DMFS无明显差别(P>0.05).结论 miR-891a-5p、miR-383-5p有可能成为HR阳性乳腺癌的一个有价值的预后相关的生物标志物和治疗肿瘤的靶点.
Exploration of the correlation between miR-891a-5p and miR-383-5p and the development of distant metastasis after surgery for early-stage hormone receptor-positive breast cancer
Objective To explore the correlation between micro RNAs(miRNAs,miR)-891a-5p and miR-383-5p and the development of distant metastasis after surgery for early-stage hormone receptor(HR)-positive breast cancer.Methods A total of 62 cases of early-stage(stage T1~2N0M0)HR-positive breast cancer patients were divided into a distant metastasis group(28 cases with distant metastasis)and a non-distant metastasis group(34 cases with no distant metastasis)according to whether there was distant metastasis after surgery.Clinical breast cancer specimens from the two groups were collected and the expression levels of miRNAs in the tissues were detected.The expression levels of miR-891a-5p,miR-383-5p,and miR-1295a were compared between the two groups to analyze the diagnostic efficiency of miR-891a-5p,miR-383-5p,and miR-1295a on distant metastasis of breast cancer.The expression levels of miR-661,miR-296-3p,and miR-128-3p in the two groups were compared,and the correlation of expression levels of miR-891a-5p,miR-383-5p,and miR-1295a with the distant metastasis-free survival(DMFS).Results The expression levels of miR-891a-5p,miR-383-5p,and miR-1295a in the distant metastasis group were significantly reduced compared with those in the non-distant metastasis group,and the multiplicity of difference were-2.519,-1.812,and-1.443.The expression of miR-891a-5p in the distant metastasis group was(1.099±0.899),which was significantly lower than(2.768±2.194)in the non-distant metastasis group(P<0.05).The sensitivity and specificity of low miR-891a-5p expression(<1.12)in predicting distant metastasis were 71.4%and 82.4%,with an area under the curve(AUC)of 0.825(P=0.0000<0.01).The sensitivity and specificity of miR-383-5p low expression(<1.15)in predicting distant metastasis were 53.4%and 85.3%,with an AUC of 0.738(P=0.0013<0.01).In contrast,the sensitivity and specificity of miR-1295a low expression(<2.08)in predicting distant metastasis were 82.1%and 50.0%,with an AUC of only 0.677(P=0.0175<0.05).In terms of diagnostic efficiency,the AUC,sensitivity,positive predictive value,and negative predictive value of miR-891a-5p in diagnosing distant metastasis of breast cancer were better than that of miR-383-5p,and the diagnostic efficacy of miR-1295a was the worst,which indicated that the low expression of miR-891a-5p and miR-383-5p could predict distant metastasis of early-stage HR-positive breast cancer.The expression levels of miR-661,miR-296-3p,and miR-128-3p in the distant metastasis group were lower than those in the non-distant metastasis group,and the difference was statistically significant(P<0.05).The follow-up time of 62 patients ranged from 59 to 131 months,and the median follow-up time was 81 months.The median DMFS of patients with low miR-891a-5p expression was 48 months,and the 5-year DMFS was only 38.5%,which was lower than 86.1%of patients with high miR-891a-5p expression(P<0.01).The median DMFS time of patients with low miR-383-5p expression was 52 months,and the 5-year DMFS was 35.0%,which was lower than 73.8%of patients with high miR-383-5p expression(P<0.01).The median DMFS in patients with low miR-1295a expression was 65 months,and there was no significant difference in 5-year DMFS between patients with high and low miR-1295a expression(P>0.05).Conclusion miR-891a-5p and miR-383-5p have the potential to be a valuable prognostic biomarker and tumor target for HR-positive breast cancer.

Micro RNAs-891a-5pMicro RNAs-383-5pHormone receptor positiveEarly-stage breast cancerDistant metastasis

张志强、郑爽、马怡、刘爽、韩彧佳、赫丽杰

展开 >

110016 辽宁省人民医院(中国医科大学人民医院)肿瘤科(放疗科)

微小RNAs-891a-5p 微小RNAs-383-5p 激素受体阳性 早期乳腺癌 远处转移

中青年科技创新人才支持计划(2021)

RC210359

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(7)
  • 15